Researchers have developed a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma.
Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.
Researchers have found new forms of tau protein that become abnormal in the very early stages of Alzheimer's disease before cognitive problems develop.
Neck, head and anal cancers linked to human papilloma viruses (HPV) could be detected early, thanks to a highly specific diagnostic test.
Doctors may be able to more accurately confirm concussions by measuring mRNA in a person's saliva, aiding diagnosis in a non-invasive, non-biased fashion.
A diagnostic made from a glass slide, Teflon film and a piece of paper can test for levels of fibrinogen concentration in blood in less than four minutes.
The Dublin-Boston score is claimed to accurately predict how severe infection will be on day seven after measuring the patient's blood for the first four days.
Researchers have traced cancer cells back to their tumour of origin by detecting an overexpression of fibroblast growth factor receptor in both the cancer cells and the tumour.
Rapid, molecular point-of-care tests can be used in remote settings to accurately detect the presence of Strep A bacterium in just six minutes.
The rapid molecular test, called N1-STOP-LAMP, involves using a small portable machine that can detect SARS-CoV-2 from just one nasal swab.
The HbA1c test measures the degree to which sugar molecules have linked irreversibly to molecules in red blood cells in the previous few months.
Blood tests based on the tau protein phospho-tau217 (p-tau217) may be able to detect changes in the brain 20 years before dementia symptoms occur.
The new test uses a single drop of blood — collected from a simple finger prick — and results are ready in a few hours.
The method has been found to detect kidney cancers with high accuracy, including small, localised tumours for which no early detection method currently exists.
A groundbreaking new test can improve the early detection of prostate cancer compared with the existing prostate-specific antigen (PSA) blood test.